Multidrug-resistant bacteria in lung transplantation.

Abstract

The review of infections in lung transplantation is beyond the scope of this article as it is a comprehensive topic, however we aim to focus on infections with multidrug-resistant (MDR) microorganisms in this patient population. New emerging clinical studies have provided data regarding outcomes in lung transplant recipients with MDR bacterial infections. Isolation of MDR bacteria from lung donors preoperatively has not been associated with worse outcomes in recipients. Patients with cystic fibrosis colonized with MDR bacteria do not have increased 1 year mortality rates compared to those without MDR bacteria.